(Swiss Verein; Zug register; principal base Geneva. This Article establishes the GRF ethics regime, conflicts-of-interest controls, sanctions/KYC/AML alignment, protected whistleblowing, and investigations/remedies. It applies to all Trustees, CB officers, Executive Management (EM), Chairs (Regional/Thematic), Stewardship Boards, NWGs, staff, secondees, consultants, and volunteers (“Covered Persons”). Cross-refs: Arts. 2 (Seat), 3 (Independence & Non-Affiliation), 4 (Membership), 5 (Definitions & Precedence), 6 (Governing Bodies), 7 (Representation), 8 (Elections/Terms), 9 (Authorities), 10 (Programs/Tracks), 11 (ECT), 12 (Meetings), 13 (CSR—Council System of Record), 14 (Financial Stewardship), 15 (Data/Security/Privacy), 18 (Disputes). Annexes: N (Conflicts & RPT Policy), M (Sanctions/KYC/AML), AB (Open Contracting & Integrity), AC (PSEA & Safeguarding), K (Election Code). EN controls; FR/DE companions provided operationally.)
16.1 Code of Ethics & Conduct
16.1.1 Purpose & Scope
(a) The Code sets the minimum standards of integrity for all Covered Persons in any capacity representing or acting on behalf of GRF.
(b) The Code is conditions-of-service for staff and conditions-of-office for elected/appointed roles; acceptance is a prerequisite to serve (Art. 8.4).
16.1.2 Core Duties
(a) Public-interest primacy: decisions advance DRR/DRF/DRI outcomes, not private gain.
(b) Independence & neutrality: comply with Art. 3; no donor/vendor/editorial influence.
(c) Honesty & fair dealing: no fraud, misrepresentation, or concealment.
(d) Respect & safeguarding: zero tolerance for harassment, exploitation or abuse; comply with PSEA (Annex AC).
(e) Non-discrimination & inclusion: uphold equal opportunity and dignity at work and in field operations.
(f) Confidentiality & proper use of information/assets: protect non-public information (Arts. 13, 15).
(g) Responsible technology & research integrity: no data/model fabrication, falsification, or plagiarism; disclose limitations and uncertainty (Art. 15.2).
(h) Environmental responsibility: prudent travel (virtual-first), carbon-aware convening, and responsible procurement (Art. 14.5).
16.1.3 Gifts, Hospitality & Benefits
(a) Prohibited: cash/cash-equivalents, loans, personal discounts, or anything intended to influence.
(b) De-minimis: customary items or hospitality ≤ CHF 150 per giver per year may be accepted if not linked to a decision; must be logged if > CHF 75.
(c) Sponsored travel/fees: require CB Pre-Clearance; speaking honoraria are paid to GRF unless expressly waived by the Board.
(d) Campaign conduct: no use of GRF funds/resources for electioneering beyond common-carrier access (Art. 8.6; Annex K).
16.1.4 Outside Activities & Political/Advocacy Neutrality
(a) Outside employment, board roles, and advisory engagements must not impair duties or independence; declare ex-ante (Art. 16.2).
(b) GRF does not engage in partisan politics or fundraising; policy engagement is evidence-based and recorded (Art. 10 Policy Track).
16.1.5 Post-Employment/Office Restrictions
(a) Cooling-off (baseline 12 months): see Art. 8.4(f) and 8.5.9 for Trustees/Chairs/CB personnel.
(b) No use of non-public information for private advantage after service.
16.2 Conflicts Register; Thresholds & Approvals; Recusals; Public Disclosures
16.2.1 Conflict Definition
A conflict of interest arises when a Covered Person’s personal, professional, financial, or family interests could improperly influence their duties. Related-party includes close family, controlled entities, beneficial ownership ≥10%, employers/clients, and, for ECT cooperation, Nexus Entities where dual roles exist.
16.2.2 Disclosure & Attestations
(a) Annual declaration of interests for all Trustees, CB officers, EM, Chairs, and voting members of GSB/RSBs/SLBs/NWGs.
(b) Event-based updates within 10 days of change.
(c) Disclosures are filed in the Conflicts & RPT Register (Art. 13.2) using Annex N forms.
16.2.3 Materiality & Thresholds (illustrative; exact bands in Annex N)
(a) Personal financial interest ≥ CHF 5,000/year or any equity/options in a counterparty to a decision = material.
(b) Gifts/benefits > CHF 150 (single) or > CHF 300 (aggregate/12 months) from any single source = material.
(c) RPT value thresholds for approvals:
• ≤ CHF 25,000 cumulative/12 months: EM approval + CB Clearance;
• > CHF 25,000–250,000: Audit & Risk recommendation + Board approval + CB Clearance;
• > CHF 250,000 or strategic: Board supermajority (≥2/3) + CB Clearance.
Aggregation applies to related contracts/options within 12 months.
16.2.4 Approval & Walls
(a) No conflicted person may participate in agenda-setting, evaluation, or award for the conflicted matter.
(b) Where an RPT is permitted, arm’s-length terms and competitive tension must be demonstrable; donor/procurement walls are documented (Annex N; AB).
(c) All approvals carry a Clearance ID and are recorded in the Council Register; material items are summarized in the Council Gazette with lawful redactions (Art. 13.3).
16.2.5 Recusal Mechanics
(a) Recusal is declared before deliberation; the chair records scope and duration in minutes (Art. 12).
(b) A conflicted member may present factual context on request but must leave for deliberation/vote.
16.2.6 Public Disclosures
(a) The annual Transparency Report (Art. 13.5) discloses aggregate conflicts/RPT statistics and material RPT summaries.
(b) Individual disclosures are published where required by law, policy, or Board decision.
16.3 Sanctions/KYC/AML Alignment (SECO/EU/OFAC)
16.3.1 Standards & Coverage
(a) GRF aligns screening and financial-crime controls with Swiss SECO, EU, and OFAC sanctions, and FATF recommendations (Annex M).
(b) Screening applies to donors, vendors, members (institutional), partners, beneficiaries of financial flows, and key personnel where relevant.
16.3.2 Due Diligence & Escalation
(a) Risk-based KYC/AML: identity, beneficial ownership, PEP status, adverse media, sector/country risk.
(b) Hits or elevated risk → CB escalation and decision with reasons; no onboarding or suspension if unresolved.
(c) Sensitive-country and export-control matters require CB opinion and sometimes Board call-in (Art. 9).
16.3.3 Monitoring & Recordkeeping
(a) Ongoing monitoring proportional to risk; rescreen at least annually.
(b) Records kept per Annex W; restricted access per Art. 13 and privacy per Art. 15.
16.4 Whistleblowing & Anti-Retaliation
16.4.1 Protected Channels
(a) Confidential hotlines (web/phone), secure email, and an independent Ombudsperson are available to staff, members, partners, suppliers, and affected communities.
(b) Anonymous reporting is permitted where lawful; CB maintains intake logs (Restricted classification).
16.4.2 Protections
(a) Zero retaliation: threats, intimidation, demotion, or dismissal for good-faith reporting are prohibited.
(b) Interim measures (safety, reassignment, paid leave) available where risk is credible.
16.4.3 Scope of Reportable Concerns
Fraud, corruption, conflicts/RPT abuse, sanctions/AML violations, PSEA and safeguarding concerns, harassment, data/privacy breaches, research integrity violations, and any material breach of the Code or bylaws.
16.4.4 Triage & Timelines
(a) Acknowledgement within 7 days; initial assessment ≤ 10 Business Days; assignment to Investigations or Management track with CB oversight.
(b) Urgent matters (safety, sanctions/AML) escalate immediately to CB and, as needed, to the Board Chair.
16.5 Investigations & Remedies
16.5.1 Authority & Independence
(a) The Ethics & Integrity Committee (a Board committee) oversees serious investigations; the CB acts as clerk and ensures chain-of-custody in the CSR.
(b) External counsel/forensic specialists may be appointed for independence or technical need.
16.5.2 Process & Due-Process Safeguards
(a) Written terms of reference, conflict checks for investigators, and notification to the subject unless this would compromise the inquiry.
(b) Subjects may respond to allegations and submit evidence.
(c) Evidence handling follows forensic protocols (hashing, sealed exhibits; Art. 13).
16.5.3 Standards of Proof & Findings
(a) Balance of probabilities for internal determinations; higher thresholds where law requires.
(b) Findings classified (e.g., substantiated, partially substantiated, unsubstantiated, unable to determine) with a reasoned report.
16.5.4 Remedies & Sanctions (Graduated)
(a) Management actions: coaching, training, written warning, restitution, process fixes.
(b) Disciplinary actions: censure, removal from committees, suspension, clawback of stipends/fees, termination/removal per Art. 8.5.
(c) Structural actions: contract termination, vendor debarment, procurement rerun, walling of donors/vendors.
(d) External actions: referral to authorities/regulators; notifications to affected parties; Gazette summary where material and lawful.
16.5.5 Appeals
Procedural appeals follow Art. 18 (mediation → Swiss Rules arbitration; seat Geneva; EN). Substantive re-hearing is exceptional and requires new evidence or manifest error.
16.5.6 Recordkeeping & Privacy
(a) Investigation files are Restricted; retention per Annex W (baseline 7 years from closure).
(b) Privacy and fair-processing notices provided to subjects/witnesses; data minimization applied; cross-border transfer safeguards per Art. 15.4.
16.6 Training, Certification & Monitoring
16.6.1 Mandatory Training
(a) Annual Code, PSEA, conflicts/RPT, sanctions/AML, and data/privacy modules for all Covered Persons.
(b) Specialized refreshers for high-risk roles (treasury, procurement, identity/CSR ops).
16.6.2 Certifications
(a) Annual ethics certification for Trustees, CB officers, EM, and Chairs; non-completion triggers suspension from decision roles.
(b) Vendors/partners certify to the Vendor Code of Conduct (Art. 14.5.4).
16.6.3 Monitoring & Reporting
(a) Quarterly dashboard to the Board: conflicts filings, RPT approvals, whistleblowing metrics, investigation cycle times, sanctions/AML hits, PSEA incidents.
(b) Trends drive policy updates to Annexes N, M, AB, AC.
16.7 Special Rules for Elections & ECT Dual-Roles
16.7.1 Elections (Trustees/Chairs)
(a) Campaign finance & conduct are governed by Art. 8.6 and Annex K; quid-pro-quo and misuse of GRF data/marks are prohibited.
(b) Violations may result in disqualification or removal (Art. 8.5).
16.7.2 Dual-Roles Across Nexus Entities
(a) Members of a governing board of one Nexus Entity who become candidates for executive roles in another must follow Art. 8.5.9 (notification, walls, resignation timelines).
(b) ECT Schedules must record walls and oversight arrangements; related decisions carry CB Clearance (Arts. 11.5, 13.2).
16.8 Enforcement, Updates & Transitional
16.8.1 Enforcement
(a) Acts in breach of this Article or executed without required CB Clearance are voidable and may trigger discipline under Art. 8.5 and remedies under §16.5.4.
(b) Repeat or willful breaches may trigger ineligibility to hold office for up to 5 years (Board-set), subject to procedural safeguards.
16.8.2 Updates
The Board reviews this Article and Annexes N/M/AB/AC annually or upon material risk change; material amendments are gazetted (Art. 13.3).
16.8.3 Transitional
Within 60 days of adoption, the CB shall: (i) publish updated disclosure forms (Annex N), (ii) deploy the Conflicts & RPT Register workflow in the CSR, (iii) issue the Whistleblowing Protocol, and (iv) run compulsory Code/PSEA training.
Design result: A coherent, Swiss-grade ethics and integrity system that prevents, detects, and remedies conflicts and abuse; aligns with global sanctions and AML norms; protects whistleblowers; and anchors every sensitive decision in a provable, gazetted record—so GRF can act at speed with trust and independence in a multipolar, polycrisis era.